ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.925
      -0.46%
      Bitcoin
      55,109.79
      -3.28%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Enanta Pharmaceuticals Inc (ENTA)

      7. Enanta Pharmaceuticals Inc (ENTA) News

      ENTA

      Enanta Pharmaceuticals (ENTA)

      Enanta Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ENTA
      DateTimeSourceHeadlineSymbolCompany
      05/12/20207:30AMBusiness WireEnanta Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/11/20204:11PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/07/20205:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/06/20204:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/06/20204:03PMBusiness WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2020 with Webcast & Conference...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/06/20204:03PMBusiness WireEnanta Announces Results of INTREPID Study of EDP-305 for the Treatment of Primary Biliary CholangitisNASDAQ:ENTAEnanta Pharmaceuticals Inc
      04/28/20204:05PMBusiness WireEnanta to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Second Quarter Ended Marc...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/26/20204:05PMBusiness WireEnanta Provides Update on Clinical Development Activities During COVID-19 PandemicNASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/16/20206:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/13/20207:00AMBusiness WireEnanta Pharmaceuticals Announces Efforts to Discover a Treatment for the Novel Coronavirus Disease COVID-19NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/06/20207:05AMBusiness WireEnanta’s HCV Collaboration Partner AbbVie Receives Marketing Authorization from European Commission to Shorten MAVIRET® (g...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/04/20204:10PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/02/20204:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/28/20205:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/28/20205:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/28/20205:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/28/20205:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/28/20205:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/18/20206:40AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/18/20206:27AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/18/20206:24AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/18/20206:23AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/18/20206:22AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/14/20201:39PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/14/20206:20AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/13/202010:33AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/12/20209:17AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/10/20204:08PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/06/20204:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      02/06/20204:00PMBusiness WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019NASDAQ:ENTAEnanta Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ENTA

      Your Recent History

      BIT
      UV4KHJ
      Unicredit Bank
      Delayed Upgrade Clock